 - Subject is unable to abstain from the use of medications known to affect platelet or clotting function, including aspirin and other nonsteroidal anti-inflammatory drugsNSAIDs, from within five half-lives of the last dose of the platelet affecting medication prior to study day 1, until the end of study follow-up. 